封面
市场调查报告书
商品编码
1544668

子宫腔镜器材市场、机会、成长动力、产业趋势分析与预测,2024-2032

Hysteroscopy Instruments Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于妇科疾病盛行率不断上升以及对微创手术的需求不断增长,子宫腔镜器械市场规模预计在 2024 年至 2032 年期间复合年增长率为 7.4%。报告显示,全球92%的女性患有一种或多种妇科疾病。子宫腔镜检查有助于以最少的手术干预对子宫腔进行详细检查和治疗。异常出血、息肉和肌瘤等疾病的发生率不断上升,再加上门诊和微创手术的转变,刺激了对先进子宫镜仪器的需求。

此外,随着医疗设施的现代化和先进妇科护理的普及,对复杂子宫镜仪器的需求不断增加。技术先进的工具(例如具有高清成像和整合功能的数位子宫腔镜)的出现,吸引了旨在提高临床结果和手术效率的医疗保健提供者,从而促进了市场成长。

整个产业分为类型、可用​​性、应用程式、最终用户和地区。

根据类型,电切镜领域的子宫腔镜器械市场价值预计到 2032 年将产生可观的收入,因为它们在诊断和治疗妇科手术中发挥关键作用。电切镜使外科医师能够从子宫腔精确切除异常组织,如息肉和肌瘤,从而增强微创治疗的有效性。

子宫腔镜诊断应用领域的子宫腔镜器械市场规模预计将在 2024 年至 2032 年期间出现强劲的复合年增长率。诊断性子宫腔镜检查能够直接观察子宫腔,确保准确辨识息肉、子宫肌瘤和子宫内膜异常等病症。妇科对早期诊断和预防性护理的日益重视推动了对能够实现精确成像和彻底检查的先进诊断工具的需求。

亚太地区子宫腔镜器械产业规模将在 2024 年至 2032 年间成长。此外,庞大且多样化的人口、不断增加的医疗保健支出以及政府努力提高获得优质医疗服务的机会,将进一步增加该地区对子宫镜检查工具的需求。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 越来越多采用微创治疗
      • 越来越多地采用办公室子宫镜检查
      • 妇科疾病发生率上升
    • 产业陷阱与挑战
      • 与子宫腔镜手术相关的副作用
      • 妇科疾病诊断和治疗的替代方案的可用性
  • 2021 年至 2032 年子宫腔镜手术总数
  • 成长潜力分析
  • 报销场景
  • 未来市场趋势
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按类型,2021 - 2032

  • 主要趋势
  • 子宫腔镜
    • 硬质子宫腔镜
    • 柔性子宫腔镜
  • 电切镜
    • 双极电切镜
    • 单极电切镜
  • 流体管理系统
  • 手持式仪器
    • 钳子
    • 剪刀
    • 扩张器
    • 其他手持式仪器
  • 子宫套
  • 子宫腔镜组织切除系统

第 6 章:市场估计与预测:按可用性划分,2021 - 2032 年

  • 主要趋势
  • 可重复使用的仪器
  • 免洗器械

第 7 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 诊断性子宫腔镜检查
  • 子宫腔镜手术
    • 子宫肌瘤切除术
    • 息肉切除术
    • 子宫内膜去除术
    • 输卵管绝育术

第 8 章:市场估计与预测:按最终用户划分,2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 9 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CooperSurgical, Inc.
  • EMOS Technology GmbH
  • Endoservice GmbH
  • Erbe Elektromedizin GmbH
  • Hologic, Inc.
  • Johnson and Johnson Services, Inc.
  • KARL STORZ SE and Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith and Nephew plc
  • Stryker Corporation
  • XION GmbH
简介目录
Product Code: 10203

Hysteroscopy instruments market size is set to record a 7.4% CAGR during 2024-2032 driven by the increasing prevalence of gynecological conditions and the rising demand for minimally invasive procedures. Reports indicate that 92% of women globally suffer from one or more gynecological diseases. Hysteroscopy facilitates a detailed examination and treatment of the uterine cavity with minimal surgical intervention. The rising incidence of conditions like abnormal bleeding, polyps, and fibroids, coupled with a shift towards outpatient and minimally invasive procedures, fuels the demand for advanced hysteroscopy instruments.

Furthermore, as medical facilities modernize and access to advanced gynecological care expands, the demand for sophisticated hysteroscopy instruments intensifies. The emergence of technologically advanced tools, such as digital hysteroscopes boasting high-definition imaging and integration capabilities, draws healthcare providers aiming to enhance clinical outcomes and procedural efficiency, adding to the market growth.

The overall industry is divided into type, usability, application, end user, and region.

Based on type, the hysteroscopy instruments market value from the resectoscopes segment is expected to generate notable revenue by 2032 due to their critical role in both diagnostic and therapeutic gynecological procedures. Resectoscopes empower surgeons to precisely resect and remove abnormal tissues, like polyps and fibroids, from the uterine cavity, bolstering the effectiveness of minimally invasive treatments.

Hysteroscopy instruments market size from the diagnostics hysteroscopy application segment is projected to observe a robust CAGR during 2024 - 2032. This is owing to its essential role in the early detection and diagnosis of uterine abnormalities. With the ability to directly visualize the uterine cavity, diagnostic hysteroscopy ensures accurate identification of conditions, such as polyps, fibroids, and endometrial abnormalities. The growing emphasis on early diagnosis and preventative care in gynecology propels the demand for advanced diagnostic tools that promise precise imaging and thorough examination.

Asia Pacific hysteroscopy instruments industry size will grow between 2024 and 2032. The rapid technological advancements in medicine, combined with an emphasis on minimally invasive procedures, are driving the adoption of advanced hysteroscopy instruments. Furthermore, the vast and varied population, increasing healthcare spending, and government efforts to enhance access to superior medical care will further bolster the regional demand for hysteroscopy tools.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing adoption of minimally invasive treatments
      • 3.2.1.2 Increasing adoption of office hysteroscopy
      • 3.2.1.3 Rising incidence of gynecological diseases
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Side effects associated with hysteroscopy procedures
      • 3.2.2.2 Availability of alternative options for diagnosis and treatment of gynecological conditions
  • 3.3 Total number of hysteroscopy procedures, 2021 - 2032
  • 3.4 Growth potential analysis
  • 3.5 Reimbursement scenario
  • 3.6 Future market trends
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hysteroscopes
    • 5.2.1 Rigid hysteroscopes
    • 5.2.2 Flexible hysteroscopes
  • 5.3 Resectoscopes
    • 5.3.1 Bipolar resectoscopes
    • 5.3.2 Unipolar resectoscopes
  • 5.4 Fluid management systems
  • 5.5 Handheld instruments
    • 5.5.1 Forceps
    • 5.5.2 Scissors
    • 5.5.3 Dilators
    • 5.5.4 Other handheld instruments
  • 5.6 Hysterosheaths
  • 5.7 Hysteroscopic tissue removal systems

Chapter 6 Market Estimates and Forecast, By Usability, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Reusable instruments
  • 6.3 Disposable instruments

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Diagnostic hysteroscopy
  • 7.3 Operative hysteroscopy
    • 7.3.1 Myomectomy
    • 7.3.2 Polypectomy
    • 7.3.3 Endometrial ablation
    • 7.3.4 Tubal sterilization

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgery centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 B. Braun Melsungen AG
  • 10.2 Boston Scientific Corporation
  • 10.3 CooperSurgical, Inc.
  • 10.4 EMOS Technology GmbH
  • 10.5 Endoservice GmbH
  • 10.6 Erbe Elektromedizin GmbH
  • 10.7 Hologic, Inc.
  • 10.8 Johnson and Johnson Services, Inc.
  • 10.9 KARL STORZ SE and Co. KG
  • 10.10 Medtronic plc
  • 10.11 Olympus Corporation
  • 10.12 Richard Wolf GmbH
  • 10.13 Smith and Nephew plc
  • 10.14 Stryker Corporation
  • 10.15 XION GmbH